From 2011 to 2019, Mednovo started with sales, step by step. Our products cover 15 departments including cardiology , interventional radiology ,neurology&neurosurgery ,vascular surgery, with a total of 28 brands and 76 product lines. We keeps great business relations with over 1500 hospitals and 4000 professional clinical departments nationwide.we rank the 1st in sales revenue, personnel size, network coverage, and the number of professional clinical departments served in the field of MII distribution.

2020 is a turning point for Mednovo and a year of layout. In this year, the company officially established Mednovo Group Co., Ltd by adjusting the strategic structure, expanding from the previous single sales to research and development, production and investment.

Subsequently, Mednovo Medical business layout gradually clear, adhere to the dual track parallel, steady and steady, not only to consolidate the main sales business, make the channel wider, make the platform stronger; It is also necessary to enrich the research and development production system, rapidly promote the commercialization of each product pipeline under each business segment, and achieve a continuous virtuous cycle of the capital chain with the listing and sales of its own products.

From single to multiple, from small to powerful, Mednovo will continue to adhere to the diversified operation of research, production and marketing in the field of minimally invasive intervention, integrate the concept of "continuous innovation and service first" into the development blood, deeply dig industry pain points and difficulties, constantly expand new business layout, improve the industrial chain and business segments, strives for becoming the world’s leading high-tech medical solution provider in the field of mini-invasive intervention!